News Release(2019)
2019
-
December 9, 2019
Positive Results from Uterine Fibroids Phase-III PRIMROSE 2 Trial of Linzagolix
-
November 26, 2019
Positive Topline Data from Pivotal Phase-III ADVOCATE Trial Demonstrating Avacopan's Superiority over Standard of Care in ANCA Vasculitis
-
November 26, 2019
Launch of "Darbepoetin Alfa BS Injection [JCR]" for the Treatment of Renal Anemia
-
September 20, 2019
Kissei Initiates Phase III Clinical Trial for Fostamatinib in Japanese Patients with Chronic Idiopathic Thrombocytopenic Purpura
-
September 20, 2019
JCR Receives Marketing Approval in Japan for Darbepoetin Alfa BS Injection JCR, a Long-Acting Erythropoiesis-Stimulating Agent
-
September 19, 2019
Launch of MINIRIN MELT® OD tablet 25µg and 50µg for the Treatment of Nocturia due to Nocturnal Polyuria in Males
-
June 18, 2019
Announcement of Co-promotion Agreement and Marketing Authorization Approval in Japan for MINIRIN MELT® OD Tablet 25µg and 50µg for Treatment of Nocturia due to Nocturnal Polyuria in Males
-
June 13, 2019
Launch of GLUBES® Combination Orally Disintegrating Tablet, a Rapid-acting Insulin Secretagogue and Agent for Postprandial Hyperglycemia
